Casey's General Stores, Inc.
CASY - NASDAQ - $859.49 ▲ +%1.00
-
Earnings Mon 8 Jun
Note: this preview was published before the 2026-06-08 earnings report. Results have since been released — verify against the latest filings.

Casey's opens the
books on Monday evening.

7 analysts' median target is $694[FMP target], stock is $859, -19.3% upside potential. After Q2 +16.3% EPS beat[FMP earnings], the stock moved +3.8%.

summary below
Quick Take - in 40 seconds
B
SELL Council 2/6 - Moonshot 33

B = MoonshotScore 33[9-pillar formula] + Council 2/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $4.2B[FMP est], EPS $3.31[FMP est]. 8 consecutive quarters of beat[FMP earnings].

$3.31 EPS Estimate Last year $2.63 - +26% YoY YoY
8 Beat Streak Expectations beaten consecutively for the last 8 quarters

Q2 EPS +16.3% beat[FMP] but the stock +3.8% D+1[FMP D+1]. Stephen Bramlage promised $183.7M CapEx + a sequential decline in Q4 during the Q2 earnings call[Stephen Bramlage capex transcript].

Watchlist

6 metrics stand out this quarter.

3% Expectation / Guide

Inside Sales Guidance

inside_sales_guidance

Casey's now expects inside same-store sales to increase between 3% to 4% and we expect an inside margin of 41% to 42% for fiscal year 2026.

"The company now expects inside same-store sales to increase between 3% to 4% and we expect an inside margin of 41% to 42%."

- Stephen Bramlage, CFO - Q2 FY26 Earnings Call - December 10, 2025
36% Risk Indicator

Grocery Margin Increase

grocery_margin_increase

Casey's continues to grow market share, supported by increased demand for higher margin items such as energy drinks and nicotine alternatives.

"The grocery and general merchandise margin was 36%, an increase of 40 basis points from the prior year. The change was impacted by a favorable mix shift within the category, as well as cost of goods management, and that includes manufacturer-funded promotional activity, associated with alternative nicotine products."

- Stephen Bramlage, CFO - Q2 FY26 Earnings Call - December 10, 2025
3.3% Investor Focus

Inside Sales Growth

inside_sales_growth

Casey's reported strong inside same-store sales growth of 3.3% for the quarter, representing a 7.5% increase on a two-year stack basis.

"Inside same-store sales were up 3.3% for the second quarter, or 7.5% on a two-year stack basis, with an average margin of 42.4%."

- Stephen Bramlage, CFO - Q2 FY26 Earnings Call - December 10, 2025
15% Expectation / Guide

Fy26 Ebitda Guidance

fy26_ebitda_guidance

Casey's has updated its fiscal year 2026 EBITDA guidance and now expects an increase of 15% to 17%.

"Fiscal 2026 EBITDA is now expected to increase 15% to 17%."

- Stephen Bramlage, CFO - Q2 FY26 Earnings Call - December 10, 2025
2% Investor Focus

Fuel Market Share Growth

fuel_market_share_growth

Casey's continues to grow market share in fuel sales despite an overall decline in the Mid Continent region.

"According to OPIS fuel gallon sold data, the Mid Continent region saw an approximate 2% decline this quarter, so we believe we are continuing to grow market share."

- Stephen Bramlage, CFO - Q2 FY26 Earnings Call - December 10, 2025
4.8% Investor Focus

Prepared Food Sales

prepared_food_sales

Casey's prepared food and dispensed beverage sales were strong, up 4.8% for the quarter, representing a 10.3% increase on a two-year stack basis.

"Same-store prepared food and dispensed beverage was quite strong, sales were up 4.8% or 10.3% on a two-year stack basis. With an average margin of 58.6%."

- Stephen Bramlage, CFO - Q2 FY26 Earnings Call - December 10, 2025

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 2 / 6 Bullish

6 investor frameworks. 2 bullish (Ken Griffin, Buffett), 3 bearish (Jim Simons, Klarman, Munger), 1 neutral (Ray Dalio).

How is it calculated? ->
Ray Dalio macro - target upside -19.3%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 75
Klarman value - target upside -19.3%
Buffett quality - ROE score 5/5
Munger valuation - target upside -19.3%
Munger's Mindset character & balance sheet lens
Overvalued

Quality business, but price is high.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyWeak
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
74.7 RSI 74.7 overbought, 50d above
MACD
+16.40 price above 50d - support positive
50d MA
$738 stock 16.4% above - short-term support
200d MA
$607 stock 41.7% above - long-term support
Volume (10d)
-27% decrease - low participation
Resistance
$694
Analyst median target - upgrade trigger if broken
Current
$859
Pre-earnings position
Support
$516
Invalidation - close below this is a technical breakdown
Pattern
Range
$516-$694 band - earnings breakout/breakdown trigger

Past Performance

Casey's beat expectations in the last 8 quarters.

BEAT
Q4 FY25
$2.63 vs $1.94 est - +11.6%
BEAT
Q1 FY26
$5.77 vs $5.02 est - +3.8%
BEAT
Q2 FY26
$5.53 vs $5.19 est - -5.3%
BEAT
Q3 FY26
$3.49 vs $3.00 est - +3.8%

Q2 (December 10, 2025): EPS $3.49 vs $3.00 est[FMP], +16.3% beat. D+1 movement: +3.8%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $3.21 (no guidance)

Q2: EPS $3.49 vs $3.00 beat[FMP], stock +3.8% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q2 earnings call.

CapEx shock

Q2 CapEx $183.7M[FMP cashflow]. Q2 op margin 7.9%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $3.31 + CapEx discipline
Threshold: EPS > $3.31[FMP est].
Target: Break above median target $694[FMP target]; high target $860[FMP] upper bound.
Scenario B - In-Line
EPS approx $3.31 + CapEx < $183.7M
Threshold: EPS approx $3.31[FMP est], Q4 CapEx < $183.7M[FMP].
Target: Consolidation in the band between current $859[FMP] and median $694[FMP].
Scenario C - Miss
EPS < $3.21 or CapEx >= $183.7M
Threshold: EPS < $3.21[FMP estx0.97].
Target: Current $859 below SMA200 $607[FMP], if rejection continues, $516[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 7 analysts say?

Wall Street Consensus
$694
12-month median target price (-19.3% upside potential)
11
BUY
7
HOLD
0
SELL
Risk Management
$516
Invalidation level - critical support threshold
$738 - 50-day MA (above, +16.4%)
$607 - 200-day MA (above, +41.7%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - CASY Q4 FY26
B

You read it in 5 minutes. When the numbers come out on Monday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Monday evening. The framework is ready on this page: Q4 EPS threshold $3.31[FMP], CapEx threshold "below $183.7M"[Stephen Bramlage]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jun 8, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jun 9, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Jul 23, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Sep 8, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the CASY earnings preview cover?

This CASY (CASY) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in CASY earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.